Kipnis J - Search Results

1

Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders.

Kipnis J, Schwartz M. Kipnis J, et al. Trends Mol Med. 2002 Jul;8(7):319-23. doi: 10.1016/s1471-4914(02)02373-0. Trends Mol Med. 2002. PMID: 12114110 Review.

2

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.

Kipnis J, Yoles E, Porat Z, Cohen A, Mor F, Sela M, Cohen IR, Schwartz M. Kipnis J, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7446-51. doi: 10.1073/pnas.97.13.7446. Proc Natl Acad Sci U S A. 2000. PMID: 10861010 Free PMC article.

3

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Schori H, Kipnis J, Yoles E, WoldeMussie E, Ruiz G, Wheeler LA, Schwartz M. Schori H, et al. Among authors: kipnis j. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3398-403. doi: 10.1073/pnas.041609498. Epub 2001 Mar 6. Proc Natl Acad Sci U S A. 2001. PMID: 11248090 Free PMC article.

4

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries.

Schwartz M, Kipnis J. Schwartz M, et al. Among authors: kipnis j. Trends Mol Med. 2001 Jun;7(6):252-8. doi: 10.1016/s1471-4914(01)01993-1. Trends Mol Med. 2001. PMID: 11378514

5

Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.

Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. Kipnis J, et al. J Neurosci. 2001 Jul 1;21(13):4564-71. doi: 10.1523/JNEUROSCI.21-13-04564.2001. J Neurosci. 2001. PMID: 11425884 Free PMC article.

6

Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.

Bakalash S, Kipnis J, Yoles E, Schwartz M. Bakalash S, et al. Among authors: kipnis j. Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2648-53. Invest Ophthalmol Vis Sci. 2002. PMID: 12147598

7

Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity.

Kipnis J, Mizrahi T, Yoles E, Ben-Nun A, Schwartz M. Kipnis J, et al. J Neuroimmunol. 2002 Sep;130(1-2):78-85. doi: 10.1016/s0165-5728(02)00219-9. J Neuroimmunol. 2002. PMID: 12225890

8

Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.

Schwartz M, Kipnis J. Schwartz M, et al. Among authors: kipnis j. Neuroscientist. 2002 Oct;8(5):405-13. doi: 10.1177/107385802236966. Neuroscientist. 2002. PMID: 12374425 Review.

9

Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'.

Schwartz M, Kipnis J. Schwartz M, et al. Among authors: kipnis j. Trends Immunol. 2002 Nov;23(11):530-4. doi: 10.1016/s1471-4906(02)02322-0. Trends Immunol. 2002. PMID: 12401405

10

Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Kipnis J, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15620-5. doi: 10.1073/pnas.232565399. Epub 2002 Nov 12. Proc Natl Acad Sci U S A. 2002. PMID: 12429857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters